• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Curr Opin Pharmacol . Molecular accuracy vs antigenic speed: SARS-CoV-2 testing strategies

tetano

Editor, Senior Moderator
Curr Opin Pharmacol


. 2021 Dec 21;62:152-158.
doi: 10.1016/j.coph.2021.12.006. Online ahead of print.
Molecular accuracy vs antigenic speed: SARS-CoV-2 testing strategies


Álvaro Fajardo[SUP] 1 [/SUP], Paula Perbolianachis[SUP] 1 [/SUP], Irene Ferreiro[SUP] 1 [/SUP], Pilar Moreno[SUP] 2 [/SUP], Gonzalo Moratorio[SUP] 3 [/SUP]



Affiliations

Abstract

The pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has hit every corner of the world faster than any infectious disease ever known. In this context, rapid and accurate testing of positive cases are essential to follow the test-trace-isolate strategy (TETRIS), which has proven to be a key approach to constrain viral spread. Here, we discuss how to interpret and combine molecular or/and antigen-based detection methods for SARS-CoV-2 as well as when they should be used. Their application can be cleverly designed as an algorithm to prevent viral dissemination according to distinct epidemiological contexts within surveillance programs.

Keywords: Antigenic test; RT-PCR; SARS-CoV-2; Testing strategies.
 
Back
Top Bottom